Salsalate activates brown adipose tissue in mice

Diabetes

Volumn 64, Issue 5, 2015, Pages 1544-1554

  Van Dam, Andrea D ^a,b   Nahon, Kimberly J ^a,b   Kooijman, Sander ^a,b   Van Den Berg, Susan M ^c   Kanhai, Anish A ^a,b   Kikuchi, Takuya ^a,b   Heemskerk, Mattijs M ^a,b   Van Harmelen, Vanessa ^a,b   Lombès, Marc ^d   Van Den Hoek, Anita M ^e   De Winther, Menno P J ^c   Lutgens, Esther ^c,f   Guigas, Bruno ^a,g   Rensen, Patrick C N ^a,b   Boon, Mariëtte R ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Einthoven Laboratory for Experimental Vascular Medicine   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d INSERM   (France)

^e Department of Metabolic Health Research ^*  (Netherlands)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; LIPID; SALSALATE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1; FAT INTAKE; SALICYLIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; CELL ACTIVATION; CELL SIZE; CONTROLLED STUDY; DIET INDUCED OBESITY; DRUG MECHANISM; FAT MASS; FATTY ACID METABOLISM; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; IN VITRO STUDY; INSULIN BLOOD LEVEL; LIPID ABSORPTION; LIPID METABOLISM; LIPID STORAGE; LIPOLYSIS; LIPOPROTEIN METABOLISM; MALE; MOLECULAR MECHANICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ADMINISTRATION AND DOSAGE; ADVERSE EFFECTS; ANIMAL; DRUG ADMINISTRATION; DRUG EFFECTS; FAT INTAKE; METABOLISM; OBESITY; PHYSIOLOGY; TRANSGENIC MOUSE; WEIGHT GAIN;

ADIPOSE TISSUE, BROWN; ANIMALS; DIETARY FATS; DRUG ADMINISTRATION SCHEDULE; GLUCOSE; LIPID METABOLISM; MALE; MICE; MICE, TRANSGENIC; OBESITY; SALICYLATES; WEIGHT GAIN;

EID: 84933545180     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1125     Document Type: Article

References (36)

1. Hawley SA, Fullerton MD, Ross FA, et al. The ancient drug salicylate directly activates AMP- Activated protein kinase. Science 2012;336:918-922.
2. Goldfine AB, Silver R, Aldhahi W, et al. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 2008;1:36-43.
3. Rumore MM, Kim KS. Potential role of salicylates in type 2 diabetes. Ann Pharmacother 2010;44:1207-1221.
4. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial. Ann Intern Med 2010;152:346-357.
5. Meex RC, Phielix E, Moonen-Kornips E, Schrauwen P, Hesselink MK. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions. J Clin Endocrinol Metab 2011;96:1415-1423.
6. Fu ZQ, Yan S, Saleh A, et al. NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants. Nature 2012;486:228-232.
7. de Haan W, van der Hoogt CC, Westerterp M, et al. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE∗3-Leiden. CETP mice. Atherosclerosis 2008;197:57-63.
8. van der Hoogt CC, de Haan W, Westerterp M, et al. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression. J Lipid Res 2007;48:1763-1771.
9. Westerterp M, van der Hoogt CC, de Haan W, et al. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE∗3-Leiden mice. Arterioscler Thromb Vasc Biol 2006;26:2552-2559.
10. Coomans CP, Geerling JJ, van den Berg SA, et al. The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system. Br J Pharmacol 2013;170:908-918.
11. Boon MR, Kooijman S, van Dam AD, et al. Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity. FASEB J 2014;28:5361-5377.
12. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 1993;34:1021-1028.
13. Rensen PC, van Dijk MC, Havenaar EC, Bijsterbosch MK, Kruijt JK, van Berkel TJ. Selective liver targeting of antivirals by recombinant chylomicrons- A new therapeutic approach to hepatitis B. Nat Med 1995;1:221-225.
14. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
15. Cariou B, Postic C, Boudou P, et al. Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 2004;145:1926-1932.
16. Zennaro MC, Le Menuet D, Viengchareun S, Walker F, Ricquier D, Lombès M. Hibernoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 1998;101:1254-1260.
17. van den Berghe N, Ouwens DM, Maassen JA, van Mackelenbergh MG, Sips HC, Krans HM. Activation of the Ras/mitogen- Activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol 1994;14:2372-2377.
18. Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell Metab 2012;15:382-394.
19. Watt MJ, Holmes AG, Pinnamaneni SK, et al. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab 2006;290:E500-E508.
20. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116:1494-1505.
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808.
22. Jakobsson A, Jörgensen JA, Jacobsson A. Differential regulation of fatty acid elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased fatty acid oxidation. Am J Physiol Endocrinol Metab 2005;289: E517-E526.
23. Geerling JJ, Boon MR, van der Zon GC, et al. Metformin lowers plasma triglycerides by promoting VLDL- Triglyceride clearance by brown adipose tissue in mice. Diabetes 2014;63:880-891.
24. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004;84:277-359.
25. Cao Y, Dubois DC, Sun H, Almon RR, Jusko WJ. Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats. J Pharmacol Exp Ther 2011;339:896-904.
26. Serizawa Y, Oshima R, Yoshida M, et al. Salicylate acutely stimulates 59-AMP- Activated protein kinase and insulin-independent glucose transport in rat skeletal muscles. Biochem Biophys Res Commun 2014;453:81-85.
27. Stanford KI, Middelbeek RJ, Townsend KL, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 2013;123: 215-223.
28. Matsushita M, Yoneshiro T, Aita S, Kameya T, Sugie H, Saito M. Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int J Obes 2013;38:812-817.
29. Fedorenko A, Lishko PV, Kirichok Y. Mechanism of fatty- Acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 2012;151:400-413.
30. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994;265:956-959.
31. Goldfine AB, Fonseca V, Jablonski KA, et al.; Targeting Inflammation Using Salsalate in Type 2 Diabetes Study Team. Salicylate (salsalate) in patients with type 2 diabetes: A randomized trial. Ann Intern Med 2013;159:1-12.
32. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008;31:289-294.
33. Yoneshiro T, Aita S, Matsushita M, et al. Recruited brown adipose tissue as an antiobesity agent in humans. J Clin Invest 2013;123:3404-3408.
34. Koska J, Ortega E, Bunt JC, et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: Results of a randomised double-blind placebo-controlled study. Diabetologia 2009;52:385-393.
35. van Marken Lichtenbelt WD, Schrauwen P. Implications of nonshivering thermogenesis for energy balance regulation in humans. Am J Physiol Regul Integr Comp Physiol 2011;301:R285-R296.
36. Vosselman MJ, van Marken Lichtenbelt WD, Schrauwen P. Energy dissipation in brown adipose tissue: from mice to men. Mol Cell Endocrinol 2013;379: 43-50.